Cargando…

Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update

Parkinson’s disease (PD) is a neurodegenerative disorder pathologically distinguished by degeneration of dopaminergic neurons in the substantia nigra pars compacta. Muscle rigidity, tremor, and bradykinesia are all clinical motor hallmarks of PD. Several pathways have been implicated in PD etiology,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gouda, Noha A., Elkamhawy, Ahmed, Cho, Jungsook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962417/ https://www.ncbi.nlm.nih.gov/pubmed/35203580 http://dx.doi.org/10.3390/biomedicines10020371

Ejemplares similares

Omarigliptin Mitigates 6-Hydroxydopamine- or Rotenone-Induced Oxidative Toxicity in PC12 Cells by Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Actions
por: Gouda, Noha A., et al.
Publicado: (2022)

Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer’s Disease, Parkinson’s Disease, and Depression with Pharmacokinetic and Safety Profiles
por: Do, Ha Thi Thu, et al.
Publicado: (2020)

Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress
por: Elsherbeny, Mohamed H., et al.
Publicado: (2021)

Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
por: Prasad, E. Maruthi, et al.
Publicado: (2021)

Future Therapeutic Strategies for Freezing of Gait in Parkinson’s Disease
por: Cui, Cathy K., et al.
Publicado: (2021)

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
por: McFarthing, Kevin, et al.
Publicado: (2021)

Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives
por: Balakrishnan, Rengasamy, et al.
Publicado: (2021)

Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin
por: Nguyen, Phuong Linh, et al.
Publicado: (2022)

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
por: Nguyen, Ngoc Minh, et al.
Publicado: (2022)

Essential updates 2021/2022: Update in surgical strategy for perihilar cholangiocarcinoma
por: Kawano, Fumihiro, et al.
Publicado: (2023)

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
por: Saleh, Maamoon, et al.
Publicado: (2022)

RNA therapeutics: updates and future potential
por: Zhang, Caroline, et al.
Publicado: (2022)

Necrotizing enterocolitis in newborns: update in pathophysiology and newly emerging therapeutic strategies
por: Choi, Young Youn
Publicado: (2014)

Digital Therapeutics in Parkinson’s Disease: Practical Applications and Future Potential
por: Ellis, Terry D., et al.
Publicado: (2021)

New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
por: Li, Chunxiao, et al.
Publicado: (2021)

GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects
por: Kotmayer, Lili, et al.
Publicado: (2022)

Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson’s Disease: An Updated Review
por: Mitchell, Steven D., et al.
Publicado: (2021)

Parkinson Disease Psychosis: Update
por: Friedman, J. H.
Publicado: (2013)

Punding in Parkinson's Disease: An Update
por: Rajalingam, Rajasumi, et al.
Publicado: (2023)

Role of Inflammation in Pathophysiology of Colonic Disease: An Update
por: Nasef, Noha Ahmed, et al.
Publicado: (2020)

Chagas’ disease: an update on immune mechanisms and therapeutic strategies
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2010)

MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
por: Polissidis, Alexia, et al.
Publicado: (2020)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
por: Sarkar, Sumit, et al.
Publicado: (2016)

Helicobacter pylori and Respiratory Diseases: 2021 Update
por: Durazzo, Marilena, et al.
Publicado: (2021)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)

Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions
por: Cho, Yongsik, et al.
Publicado: (2021)

Update on Parkinson’s Disease Rehabilitation
por: Yoon, Seo Yeon
Publicado: (2022)

Gene Therapy for Parkinson’s Disease, An Update
por: Axelsen, Tobias M., et al.
Publicado: (2018)

Update on CSF Biomarkers in Parkinson’s Disease
por: Kwon, Eun Hae, et al.
Publicado: (2022)

Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
por: De Lazzari, Federica, et al.
Publicado: (2018)

Targeted alpha anticancer therapies: update and future prospects
por: Allen, Barry J, et al.
Publicado: (2014)

Emerging regenerative medicine and tissue engineering strategies for Parkinson’s disease
por: Harris, James P., et al.
Publicado: (2020)

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
por: Sun, Chengmei, et al.
Publicado: (2020)

Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson’s Disease
por: Kumari, Nitu, et al.
Publicado: (2023)

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
por: Schneider, Susanne A., et al.
Publicado: (2020)

Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
por: Kwon, Destany K., et al.
Publicado: (2022)

Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
por: Li, Chunxiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_utct217atcagfl4bspdfoct4lu